HPV associated disease is a global health problem: 5.2% of all cancers are HPV associated
with HPV 16 and 18 accounting for 70% of cases of cervical cancer. Genital warts caused by …

Cervical cancer is an important public health problem worldwide, and especially in
developing countries. The link between cervical cancer and oncogenic human …

Benign and malignant disease caused by HPV (human papillomavirus) constitutes a global
public health problem. Genital warts are the commonest viral sexually transmitted infection …

With the development of viral-like particles and the relatively short translation to phase 3
clinical vaccine trials showing that prophylactic HPV vaccines targeting the two most …

Genital human papillomavirus (HPV) infection and HPV‐associated cervical and other
anogenital cancers are significant public health problems. HPV 16 and HPV 18 are …

Countries are now challenged by the rapid development of vaccines aimined at the primary
prevention of infections. In the years to come, several vaccines will need to be considered as …

Human papillomaviruses are DNA viruses that infect skin or mucosal cells. In the genital
tract HPV (especially types 6 and 11) cause genital warts, the commonest viral sexually …

Prophylactic HPV vaccination provides an opportunity to profoundly affect cervical cancer
incidence worldwide. The quadrivalent HPV VLP 6, 11, 16, 18 vaccine (Gardasil®) and the …

Since 2006, three vaccines against infections and disease caused by human papillomavirus
(HPV) became available in Europe—in 2006 a quadrivalent HPV 6/11/16/18 vaccine, in …

Human papillomavirus (HPV) is causally associated with 5% of cancers, including cancers
of the cervix, penis, vulva, vagina, anus and oropharynx. The most carcinogenic HPV is HPV …